GLP‑1 agonists are a type of medication commonly used to treat type 2 diabetes and obesity. They work by mimicking a natural hormone in the body called GLP‑1, which is released after eating.

This hormone helps:

• Lower blood sugar
• Slow down stomach emptying (helps you feel full longer)
• Reduce appetite, making it easier to lose weight

By copying these effects, GLP‑1 agonists improve blood‑sugar control and support weight loss.

Examples: Ozempic and Wegovy (semaglutide)  |  Mounjaro (tirzepatide)

Yes—GLP‑1 medications are generally safe when prescribed by a qualified healthcare professional. They have been rigorously tested in clinical trials and approved by health agencies worldwide.

Like all medicines, they can cause side‑effects and may not be right for everyone. That’s why Obeva always checks your health history to be sure the treatment is safe and appropriate for you.

1. Type 2 Diabetes

• Adults who need an add‑on to diet + exercise when other medicines aren’t controlling blood sugar

2. Obesity / Over‑weight

• BMI ≥ 30 kg/m² (obese) or
• BMI ≥ 27 kg/m² plus at least one weight‑related issue:
  high blood pressure, high cholesterol, obstructive sleep apnea, fatty liver, pre‑diabetes, etc.

Short‑Term (first 4–8 weeks)

• Lower blood sugar (if diabetic)
• Reduced appetite
• 1–3 kg weight loss

Medium‑Term (3–6 months)

• 5–10 % body‑weight loss
• Stable blood sugar
• Clothes fit better

Long‑Term (6–12 months +)

• 15–20 % body‑weight loss (especially on higher doses)

Keep in mind:

• Everyone responds differently
• Doses are increased gradually, so full effects can take months
• Consistency with healthy eating and movement is key

Before prescribing, Obeva reviews your medical history, current conditions, and all medicines you take. This ensures any treatment—such as a GLP‑1 medication—is both safe and effective for you.

If a GLP‑1 isn’t suitable, we’ll recommend alternative options to support your weight‑loss goals safely.

News reports can be alarming, but isolated stories don’t reflect the overall safety and effectiveness of GLP‑1 medicines.

Obeva prescribes GLP‑1s only after carefully evaluating your needs and ensuring low risk. If you have concerns, reach out—our team is here to help you make confident treatment decisions.

Some people experience mild, short‑lived side‑effects while their body adjusts:

• Nausea
• Vomiting
• Diarrhoea
• Stomach pain
• Constipation
• Reduced appetite
• Fatigue

Symptoms usually fade after a few days. If they persist, Obeva’s 24‑hour support team is ready to help.

If you’re thinking about pausing or stopping, please talk to Obeva first. We’ll help you taper safely and explore other strategies to keep you on track with your weight‑loss goals.